{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:49:34Z","timestamp":1793108974170,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11239-015-1308-1","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T13:38:47Z","timestamp":1452951527000},"page":"129-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Guidance for the management of venous thrombosis in unusual sites"],"prefix":"10.1007","volume":"41","author":[{"given":"Walter","family":"Ageno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Beyer-Westendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"1308_CR1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664\u2013670","journal-title":"Stroke"},{"key":"1308_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","volume":"6","author":"MG Bousser","year":"2007","unstructured":"Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162\u2013170","journal-title":"Lancet Neurol"},{"key":"1308_CR3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2005-12-4795","volume":"108","author":"F Dentali","year":"2006","unstructured":"Dentali F, Gianni M, Crowther MA, Ageno W (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108:1129\u20131134","journal-title":"Blood"},{"key":"1308_CR4","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1161\/CIRCULATIONAHA.109.927046","volume":"121","author":"I Martinelli","year":"2010","unstructured":"Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM (2010) Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation 121:2740\u20132746","journal-title":"Circulation"},{"key":"1308_CR5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1538-7836.2012.04774.x","volume":"10","author":"F Dentali","year":"2012","unstructured":"Dentali F, Poli D, Scoditti U, Di Minno MN, Stefano VD, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W (2012) Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 10:1297\u20131302","journal-title":"J Thromb Haemost"},{"key":"1308_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","volume":"8","author":"MR Thatipelli","year":"2010","unstructured":"Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE (2010) Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol 8:200\u2013205","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1308_CR7","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","volume":"120","author":"JH Smalberg","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HLA, Leebeek FWG (2012) Myeloproliferative neoplasms in Budd\u2013Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120:4921\u20134928","journal-title":"Blood"},{"key":"1308_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ncpgasthep0143","volume":"2","author":"M Senzolo","year":"2005","unstructured":"Senzolo M, Cholongitas EC, Patch D, Burroughs AK (2005) Update on the classification, assessment of prognosis and therapy of Budd\u2013Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2:182\u2013190","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1308_CR9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","volume":"120","author":"B Condat","year":"2001","unstructured":"Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120:490\u2013497","journal-title":"Gastroenterology"},{"key":"1308_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","volume":"11","author":"MCW Spaander","year":"2013","unstructured":"Spaander MCW, Hoekstra J, Hansen BE, van Buuren HR, Leebek FWG (2013) Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 11:452\u2013459","journal-title":"J Thromb Haemost"},{"key":"1308_CR11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1160\/TH08-12-0842","volume":"102","author":"F Dentali","year":"2009","unstructured":"Dentali F, Ageno W, Witt D, Malato A, Clark N, Garcia D, McCool K, Siragusa S, Dyke S, Crowther M (2009) Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost 102:501\u2013504","journal-title":"Thromb Haemost"},{"key":"1308_CR12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","volume":"111","author":"The Central Vein Occlusion Study Group","year":"1993","unstructured":"The Central Vein Occlusion Study Group (1993) Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 111:1087\u20131095","journal-title":"Arch Ophthalmol"},{"key":"1308_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11739-010-0478-2","volume":"6","author":"R Marcucci","year":"2011","unstructured":"Marcucci R, Sofi F, Grifoni E, Sodi A, Prisco D (2011) Retinal vein occlusion: a review for the internist. Intern Emerg Med 6:307\u2013314","journal-title":"Intern Emerg Med"},{"key":"1308_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","volume":"33","author":"J Rehak","year":"2008","unstructured":"Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111\u2013131","journal-title":"Curr Eye Res"},{"key":"1308_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","volume":"115","author":"The Central Vein Occlusion Study Group","year":"1997","unstructured":"The Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115:486\u2013491","journal-title":"Arch Ophthalmol"},{"key":"1308_CR16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ophtha.2010.01.060","volume":"117","author":"RL McIntosh","year":"2010","unstructured":"McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY (2010) Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1113\u20131123","journal-title":"Ophthalmology"},{"key":"1308_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-Q","volume":"338","author":"KM Einhaupl","year":"1991","unstructured":"Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597\u2013600","journal-title":"Lancet"},{"key":"1308_CR18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.STR.30.3.484","volume":"30","author":"SF Bruijn de","year":"1999","unstructured":"de Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484\u2013488","journal-title":"Stroke"},{"key":"1308_CR19","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/STROKEAHA.111.648162","volume":"43","author":"JM Coutinho","year":"2012","unstructured":"Coutinho JM, De Bruijn SF, DeVeber G, Stam J (2012) Anticoagulation for cerebral venous sinus thrombosis. Stroke 43:e41\u2013e42","journal-title":"Stroke"},{"key":"1308_CR20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarramenteria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42:1158\u20131192","journal-title":"Stroke"},{"key":"1308_CR21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1468-1331.2010.03011.x","volume":"17","author":"K Einhaupl","year":"2010","unstructured":"Einhaupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, Masuhr F (2010) EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 17:1229\u20131235","journal-title":"Eur J Neurol"},{"key":"1308_CR22","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","volume":"141","author":"MG Lansberg","year":"2012","unstructured":"Lansberg MG, O\u2019Donnell MJ, Khatri P, Lang ES, Nguyen-Huynh MN, Schwartz NE, Sonnenberg FA, Schulman S, Vandvik PO, Spencer FA, Alonso-Coello P, Guyatt GH, Akl EA (2012) Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 141:e601S\u2013e636S","journal-title":"Chest"},{"key":"1308_CR23","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/STROKEAHA.110.588822","volume":"41","author":"JM Coutinho","year":"2010","unstructured":"Coutinho JM, Ferro JM, Canhao P, Barinagarrementeria F, Bousser MG, Stam J (2010) Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 41:2575\u20132580","journal-title":"Stroke"},{"key":"1308_CR24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000330646","volume":"32","author":"JM Coutinho","year":"2011","unstructured":"Coutinho JM, Seelig R, Bousser MG, Canhao P, Ferro JM, Stam J (2011) Treatment variations in cerebral venous thrombosis: an international survey. Cerebrovasc Dis 32:298\u2013300","journal-title":"Cerebrovasc Dis"},{"key":"1308_CR25","first-page":"132","volume-title":"Handbook on cerebral venous thrombosis. Front Neurol Neurosci","author":"F Masuhr","year":"2008","unstructured":"Masuhr F, Einhaupl K (2008) Treatment of cerebral venous thrombosis. In: Caso V, Agnelli G, Paciaroni M (eds) Handbook on cerebral venous thrombosis. Front Neurol Neurosci, vol 23. Karger, Basel, pp 132\u2013143"},{"key":"1308_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00415-011-6307-3","volume":"259","author":"SM Zuurbier","year":"2012","unstructured":"Zuurbier SM, Couthinho JM, Majoie CBLM, Coert BA, van den Munckhof P, Stam J (2012) Decompressive hemicraniectomy in severe cerebral venous thrombosis: a prospective case series. J Neurol 259:109\u20131105","journal-title":"J Neurol"},{"key":"1308_CR27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1160\/TH09-12-0827","volume":"103","author":"W Ageno","year":"2010","unstructured":"Ageno W, Dentali F, Squzzato A, Baglin T, Douketis J, Lansberg M, Paciaroni M, Palareti G (2010) Evidence and clinical judgment: treatment of cerebral vein thrombosis. Thromb Haemost 103:1109\u20131115","journal-title":"Thromb Haemost"},{"key":"1308_CR28","first-page":"CD003693","volume":"1","author":"A Ciccone","year":"2004","unstructured":"Ciccone A, Canh\u00e3o P, Falc\u00e3o F, Ferro JM, Sterzi R (2004) Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 1:CD003693","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1308_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000068833","volume":"15","author":"P Canh\u00e3o","year":"2003","unstructured":"Canh\u00e3o P, Falc\u00e3o F, Ferro JM (2003) Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 15(3):159\u2013166","journal-title":"Cerebrovasc Dis"},{"key":"1308_CR30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1160\/TH10-05-0311","volume":"104","author":"F Dentali","year":"2010","unstructured":"Dentali F, Squizzato A, Gianni M, de Lodovici ML, Venco A, Paciaroni M, Crowther M, Ageno W (2010) Safety of thrombolysis in cerebral venous thrombosis: a systematic review of the literature. Thromb Haemost 104:1055\u20131062","journal-title":"Thromb Haemost"},{"key":"1308_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000356840","volume":"37","author":"LD Viegas","year":"2014","unstructured":"Viegas LD, Stolz E, Canhao P, Ferro JM (2014) Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review. Cerebovasc Dis 37:43\u201350","journal-title":"Cerebovasc Dis"},{"key":"1308_CR32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.110.581223","volume":"41","author":"B Miranda","year":"2010","unstructured":"Miranda B, Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U (2010) Venous thromboembolic events after cerebral vein thrombosis. Stroke 41:1901\u20131906","journal-title":"Stroke"},{"key":"1308_CR33","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/STROKEAHA.114.006167","volume":"45","author":"C Geisb\u00fcsch","year":"2014","unstructured":"Geisb\u00fcsch C, Richter D, Herweh C, Ringleb PA, Nagel S (2014) Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke 45:2469\u20132471","journal-title":"Stroke"},{"key":"1308_CR34","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","volume":"102","author":"L Amitrano","year":"2007","unstructured":"Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Armes PR, Iannaccone L, Grandone E, Romano L, Balzano A (2007) Prognostic factors in noncirrhotic patients with splanchnic vein thrombosis. Am J Gastroenterol 102:2464\u20132470","journal-title":"Am J Gastroenterol"},{"key":"1308_CR35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","volume":"51","author":"A Plessier","year":"2010","unstructured":"Plessier A, Darwish Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D (2010) Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicentre follow-up study. Hepatology 51:210\u2013218","journal-title":"Hepatology"},{"key":"1308_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1538-7836.2011.04565.x","volume":"10","author":"W Ageno","year":"2012","unstructured":"Ageno W, Squizzato A, Togna A, Magistrali F, Mangini M, Fugazzola C, Dentali F (2012) Incidental diagnosis of deep vein thrombosis in consecutive patients undergoing a CT scan of the abdomen: a retrospective cohort study. J Thromb Haemost 10:158\u2013160","journal-title":"J Thromb Haemost"},{"key":"1308_CR37","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR, American College of Chest Physicians (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e419S\u2013e494S","journal-title":"Chest"},{"key":"1308_CR38","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve LD, Valla DC, Garcia-Tsao G (2009) Vascular disorders of the liver. Hepatology 49:1729\u20131764","journal-title":"Hepatology"},{"key":"1308_CR39","first-page":"99","volume":"40","author":"W Ageno","year":"2014","unstructured":"Ageno W, Riva N, Schulman S, Bang SM, Sartori MT, Grandone E, Beyer-Westendorf J, Barillari G, Di Minno MN, Dentali F (2014) Antithrombotic treatment of splanchnic vein thrombosis: results of an International registry. Semin Thromb Hemost 40:99\u2013105","journal-title":"Semin Thromb Hemost"},{"key":"1308_CR40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","volume":"32","author":"M Senzolo","year":"2012","unstructured":"Senzolo M, Sartori MT, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, Burroughs K (2012) Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Intern 32:919\u2013927","journal-title":"Liver Intern"},{"key":"1308_CR41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","volume":"10","author":"MG Delgado","year":"2012","unstructured":"Delgado MG, Seijo S, Yepes I et al (2012) Efficacy and safety of anticoagulation on individuals with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 10:776\u2013783","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1308_CR42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0741-5214(03)01052-8","volume":"38","author":"EA Henao","year":"2003","unstructured":"Henao EA, Bohannon WT, Silva MB Jr (2003) Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vasc Surg 38:1411\u20131415","journal-title":"J Vasc Surg"},{"key":"1308_CR43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1046\/j.1440-1746.2001.02557.x","volume":"16","author":"A Tateishi","year":"2001","unstructured":"Tateishi A, Mitsui H, Oki T, Morishita J, Maekawa H, Yahagi N, Maruyama T, Ichinose M, Ohnishi S, Shiratori Y, Minami M, Koutetsu S, Hori N, Watanabe T, Nagawa H, Omata M (2001) Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation. J Gastroenterol Hepatol 16:1429\u20131433","journal-title":"J Gastroenterol Hepatol"},{"key":"1308_CR44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0720-048X(01)00289-3","volume":"39","author":"C Aytekin","year":"2001","unstructured":"Aytekin C, Boyvat F, Kurt A, Yologlu Z, Coskun M (2001) Catheter directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol 39:80\u201382","journal-title":"Eur J Radiol"},{"key":"1308_CR45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mva.2002.127526","volume":"36","author":"JE Lopera","year":"2002","unstructured":"Lopera JE, Correa G, Brazzini A, Ustunsoz B, Patel S, Janchai A, Castaneda-Zuniga W (2002) Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 36:1058\u20131061","journal-title":"J Vasc Surg"},{"key":"1308_CR46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","volume":"16","author":"M Hollingshead","year":"2005","unstructured":"Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF (2005) Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 16:651\u2013661","journal-title":"J Vasc Interv Radiol"},{"key":"1308_CR47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","volume":"100","author":"JH Smalberg","year":"2008","unstructured":"Smalberg JH (2008) Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 100:1084\u20131088","journal-title":"Thromb Haemost"},{"key":"1308_CR48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH13-05-0407","volume":"110","author":"S Pannach","year":"2013","unstructured":"Pannach S, Babatz J, Beyer-Westendorf J (2013) Successful treatment of acute portal vein thrombosis with rivaroxaban. Thromb Haemost 110:626\u2013627","journal-title":"Thromb Haemost"},{"key":"1308_CR49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.26998","volume":"60","author":"M Martinez","year":"2014","unstructured":"Martinez M, Tandra A, Vuppalanchi R (2014) Treatment of acute portal vein thrombosis by non-traditional anticoagulation. Hepatology 60:425\u2013426","journal-title":"Hepatology"},{"key":"1308_CR50","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e44S\u2013e88S","journal-title":"Chest"},{"key":"1308_CR51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH09-09-0626","volume":"103","author":"A Squizzato","year":"2010","unstructured":"Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W (2010) Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 103:271\u2013276","journal-title":"Thromb Haemost"},{"key":"1308_CR52","first-page":"219","volume":"15","author":"AJ Houtsmuller","year":"1984","unstructured":"Houtsmuller AJ, Vermeulen JA, Klompe M, Zahn KJ, Henkes HE, Baarsma GS, Tijssen J (1984) The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 15:219\u2013229","journal-title":"Agents Actions Suppl"},{"key":"1308_CR53","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2011.04.036","volume":"118","author":"SS Hayreh","year":"2011","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman MB (2011) Central and hemi-central retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulant. Ophthalmology 118:1603\u20131611","journal-title":"Ophthalmology"},{"key":"1308_CR54","unstructured":"The Royal College of Ophthalmologists Interim Guidelines for Management of Retinal Vein Occlusion. December 2010 http:\/\/www.rcophth.ac.uk\/page.asp?section=451"},{"key":"1308_CR55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000073587","volume":"32","author":"D Prisco","year":"2002","unstructured":"Prisco D, Marcucci R (2002) Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 32:308\u2013311","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1308_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2009.05.007","volume":"125","author":"W Ageno","year":"2010","unstructured":"Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D\u2019Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D (2010) Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Thromb Res 125:137\u2013141","journal-title":"Thromb Res"},{"key":"1308_CR57","first-page":"539","volume":"11","author":"MS Farahvash","year":"2008","unstructured":"Farahvash MS, Farahvash MM, Moradimogadam M, Mohammadzadeh S (2008) Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. Arch Iran Med 11:539\u2013543","journal-title":"Arch Iran Med"},{"key":"1308_CR58","first-page":"418","volume":"11","author":"MS Farahvash","year":"2008","unstructured":"Farahvash MS, Moradimogadam M, Farahvash MM, Mohammadzadeh S, Mirshahi A (2008) Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial. Arch Iran Med 11:418\u2013422","journal-title":"Arch Iran Med"},{"key":"1308_CR59","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3324\/haematol.2010.023614","volume":"95","author":"A Lazo-Langner","year":"2010","unstructured":"Lazo-Langner A, Hawell J, Ageno W, Kovacs MJ (2010) Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica 95:1587\u20131593","journal-title":"Haematologica"},{"key":"1308_CR60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.1.6009.550","volume":"1","author":"EM Kohner","year":"1976","unstructured":"Kohner EM, Pettit JE, Hamilton AM, Bulpitt CJ, Dollery CT (1976) Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1:550\u2013553","journal-title":"Br Med J"},{"key":"1308_CR61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/IAE.0b013e3181a3b870","volume":"29","author":"LO Hattenbach","year":"2009","unstructured":"Hattenbach LO, Friedrich Arndt C, Lerche R, Scharrer I, Baatz H, Margaron F, Richard G, Behrens-Baumann W, Ohrloff C (2009) Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 29:932\u2013940","journal-title":"Retina"},{"key":"1308_CR62","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bjo.81.8.698","volume":"81","author":"TH Williamson","year":"1997","unstructured":"Williamson TH (1997) Central retinal vein occlusion: what\u2019s the story? Br J Ophthalmol 81:698\u2013704","journal-title":"Br J Ophthalmol"},{"key":"1308_CR63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(14)70001-7","volume":"117","author":"SS Hayreh","year":"1994","unstructured":"Hayreh SS, Zimmerman MB, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117:429\u2013441","journal-title":"Am J Ophthalmol"},{"key":"1308_CR64","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-9394(14)71345-5","volume":"116","author":"The Eye Disease Case-Control Study Group","year":"1996","unstructured":"The Eye Disease Case-Control Study Group (1996) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116:286\u2013296","journal-title":"Am J Ophthalmol"},{"key":"1308_CR65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","volume":"114","author":"The Eye disease case-control study group","year":"1996","unstructured":"The Eye disease case-control study group (1996) Risk factors for central retinal vein occlusion. Arch Ophthalmol 114:545\u2013554","journal-title":"Arch Ophthalmol"},{"key":"1308_CR66","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","volume":"114","author":"P Mitchell","year":"1996","unstructured":"Mitchell P, Smith W, Chang A (1996) Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountain Eye study. Arch Ophthalmol 114:1243\u20131247","journal-title":"Arch Ophthalmol"},{"key":"1308_CR67","first-page":"114","volume":"104","author":"PM Dodson","year":"1985","unstructured":"Dodson PM, Kritzinger EE (1985) Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 104:114\u2013119","journal-title":"Trans Ophthalmol Soc UK"},{"key":"1308_CR68","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.86.7.774","volume":"86","author":"SC Martin","year":"2002","unstructured":"Martin SC, Butcher A, Martin N (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86:774\u2013776","journal-title":"Br J Ophthalmol"},{"key":"1308_CR69","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2006.06.061","volume":"114","author":"S Cugati","year":"2007","unstructured":"Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BEK, Wong TY, Mitchell P (2007) Retinal vein occlusion and vascular mortality. Ophthalmology 114:520\u2013524","journal-title":"Ophthalmology"},{"key":"1308_CR70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcjo.2012.08.017","volume":"48","author":"Z Khan","year":"2013","unstructured":"Khan Z, Almeida DR, Rahim K, Belliveau MJ, Bona M, Gale J (2013) 10-Year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis. Can J Ophthalmol 48:40\u201345","journal-title":"Can J Ophthalmol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1308-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1308-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T15:17:43Z","timestamp":1567523863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1308-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}